In Situ Hybridization Market by Technology, End-user, and Geography - Forecast and Analysis 2021-2025

  • Published: Apr 2021
  • Pages: 120
  • SKU: IRTNTR40880
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The in situ hybridization (ISH) market has the potential to grow by USD 475.05 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 7.05%.

This in situ hybridization market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by technology (FISH and CISH), end-user (molecular diagnostic laboratories, pharmaceutical and biotechnological companies, and others), and geography (North America, Europe, Asia, and ROW). The in situ hybridization market report also offers information on several market vendors, including Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. among others.

What will the In Situ Hybridization (ISH) Market Size be in 2021?

In-Situ-Hybridization-(ISH)-Market-Market-Size-2020-2025

Browse TOC and LoE with selected illustrations and example pages of In Situ Hybridization (ISH) Market

 Get Your FREE Sample Now!

In Situ Hybridization (ISH) Market: Key Drivers and Trends

The increasing demand for companion diagnostic tests is notably driving the ISH market growth, although factors such as emergence of alternative techniques may impede market growth. To unlock information on the key market drivers and the COVID-19 pandemic impact on the in situ hybridization industry get your FREE report sample now.

  • The growing demand for companion diagnostic tests will be a major factor driving the growth of the in situ hybridization market.
  • Regulatory organizations across the globe have made it mandatory to include information about companion diagnostic tests in the label of the corresponding therapeutic drug and on the package of the diagnostic device itself.
  • There has been a recent surge in interest among patients and HCPs to explore the importance of and acceptability of companion diagnostics.
  • The growth in companion diagnostics has contributed to the rise in demand for ISH technologies, particularly for oncology drugs. 
  • The launch of several nation-wide initiatives to facilitate molecular research activities particularly applications of ISH are boosting the adoption of ISH techniques and paving the way for future medicines.
  • In Australia, the Australian HER2 Testing Advisory Board mandated the use of ISH testing, and patients with HER2 gene amplification were diagnosed.
  • The National Science Foundation of the US Department of Agriculture has awarded USD 2.1 million in grants to support a series of early-stage microbiome research projects, supporting Marine Biological Laboratory to develop new sample preparation protocols and FISH probes for use in animal research.

This in situ hybridization market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. Get detailed insights on the trends and challenges, which will help companies evaluate and develop growth strategies.

Who are the Major In Situ Hybridization (ISH) Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corp.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • NeoGenomics Laboratories, Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

 

The ISH market is fragmented and the vendors are deploying growth strategies such as entering into partnerships or merging for product development to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the in situ hybridization market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for In Situ Hybridization (ISH) Market?

In-Situ-Hybridization-(ISH)-Market-Market-Share-by-Region-2020-2025

For more insights on the market share of various regions Request for a FREE sample now!

43% of the market’s growth will originate from North America during the forecast period. The US is a key market for in situ hybridization in North America. However, market growth in this region will be slower than the growth of the market in Asia.

The increasing demand for ISH techniques for the detection and treatment plan of various types of cancer and rare disorders will facilitate the in situ hybridization market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.

What are the Revenue-generating Technology Segments in the In Situ Hybridization (ISH) Market?

In-Situ-Hybridization-(ISH)-Market-Market-Share-by-Technology-2020-2025

To gain further insights on the market contribution of various segments Request for a FREE sample

The in situ hybridization market share growth by the FISH segment will be significant during the forecast period. FISH can detect cancer mutations, cancer-causing genes, as well as rare genetic disorders such as Angelman syndrome, Prader-Willi syndrome, acute lymphoblastic leukemia, chronic myelogenous leukemia, cri-du-chat disease, and Down syndrome. The prevalence of these rare diseases along with the high incidence and prevalence of cancer across the globe contributes to the higher demand for FISH in the market.

Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the in situ hybridization market size.

 

Event-Tickets-Market-Report

Request for a FREE sample

What are the Key Factors Covered in this In Situ Hybridization (ISH) Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive in-situ hybridization market growth during the next five years
  • Precise estimation of the ISH market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the in situ hybridization industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of in situ hybridization market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

In Situ Hybridization (ISH) Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 7%

Market growth 2021-2025

$ 475.05 million

Market structure

Fragmented

YoY growth (%)

6.80

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 43%

Key consumer countries

US, Germany, Japan, France, and Australia

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Market characteristics
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Technology

    • Market segments
    • Comparison by Technology
    • FISH - Market size and forecast 2020-2025
    • CISH - Market size and forecast 2020-2025
    • COVID-19 impact and recovery for technology segment
    • Market opportunity by Technology

    Market Segmentation by End-user

    • Market segments
    • Comparison by End user
    • Molecular diagnostic laboratories - Market size and forecast 2020-2025
    • Pharmaceutical and biotechnological companies - Market size and forecast 2020-2025
    • Others - Market size and forecast 2020-2025
    • COVID-19 impact and recovery for end-user segment
    • Market opportunity by End user

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2020-2025
      • Europe - Market size and forecast 2020-2025
      • Asia - Market size and forecast 2020-2025
      • ROW - Market size and forecast 2020-2025
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Competitive scenario
      • Vendor landscape
      • Landscape disruption
      • Industry risks

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Abbott Laboratories
      • Agilent Technologies Inc.
      • Bio-Rad Laboratories Inc.
      • Bio-Techne Corp.
      • F. Hoffmann-La Roche Ltd.
      • Merck KGaA
      • PerkinElmer Inc.
      • QIAGEN NV
      • Thermo Fisher Scientific Inc.

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your FREE sample now!
      The in situ hybridization (ish) market growth will increase by $475.05 million during 2020-2025.
      The in situ hybridization (ish) market is expected to grow at a CAGR of 7.05% during 2020-2025.
      Technavio has segmented the in situ hybridization (ish) market by technology (FISH and CISH) ,end user (Molecular diagnostic laboratories, Pharmaceutical and biotechnological companies, and Others) , and geographic (North America, Europe, Asia, and ROW).
      Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, Thermo Fisher Scientific Inc. are a few of the key vendors in the in situ hybridization (ish) market.
      North America will register the highest growth rate of 42.82% among the other regions. Therefore, the in situ hybridization (ish) market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
      The key factors driving the in situ hybridization (ish) market growth are:
      • Growing incidence and prevalence of cancer
      The in situ hybridization (ish) market vendors should focus on grabbing business opportunities from the fish segment as it accounted for the largest market share in the base year.
      Safe and Secure SSL Encrypted
      Technavio

      Single User:

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Want to customize this report?

      This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

      We offer $1000 worth of FREE customization at the time of purchase
      Technavio
      Enquire Before Buying
      1. Home
      2. Health Care
      3. Published Report
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>